These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7720047)
1. Controversies in the local management of invasive and non-invasive breast cancer. Page DL; Johnson JE Cancer Lett; 1995 Mar; 90(1):91-6. PubMed ID: 7720047 [TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. Lagios MD; Silverstein MJ Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503 [TBL] [Abstract][Full Text] [Related]
3. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy? Valdes EK; Boolbol SK; Cohen JM; Feldman SM Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481 [TBL] [Abstract][Full Text] [Related]
4. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery. Ohuchi N; Furuta A; Mori S Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451 [TBL] [Abstract][Full Text] [Related]
5. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [TBL] [Abstract][Full Text] [Related]
6. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer? Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789 [TBL] [Abstract][Full Text] [Related]
7. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Boyages J; Delaney G; Taylor R Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735 [TBL] [Abstract][Full Text] [Related]
8. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance. Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734 [TBL] [Abstract][Full Text] [Related]
9. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616 [TBL] [Abstract][Full Text] [Related]
10. Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ. Ekatah GE; Turnbull AK; Arthur LM; Thomas J; Dodds C; Dixon JM Eur J Surg Oncol; 2017 Nov; 43(11):2029-2035. PubMed ID: 28917445 [TBL] [Abstract][Full Text] [Related]
11. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer]. Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer. Choi YJ; Shin YD; Song YJ World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Jimenez RE; Bongers S; Bouwman D; Segel M; Visscher DW Am J Surg Pathol; 2000 Jan; 24(1):123-8. PubMed ID: 10632496 [TBL] [Abstract][Full Text] [Related]
16. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Slavin SA; Schnitt SJ; Duda RB; Houlihan MJ; Koufman CN; Morris DJ; Troyan SL; Goldwyn RM Plast Reconstr Surg; 1998 Jul; 102(1):49-62. PubMed ID: 9655407 [TBL] [Abstract][Full Text] [Related]
17. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. Amichetti M; Caffo O; Richetti A; Zini G; Rigon A; Antonello M; Arcicasa M; Coghetto F; Valdagni R; Maluta S; Di Marco A Eur J Cancer; 1997 Sep; 33(10):1559-65. PubMed ID: 9389915 [TBL] [Abstract][Full Text] [Related]
18. Updates in the treatment of ductal carcinoma in situ of the breast. Lebeau A; Kühn T Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830 [TBL] [Abstract][Full Text] [Related]
19. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623 [TBL] [Abstract][Full Text] [Related]
20. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Chan LW; Rabban J; Hwang ES; Bevan A; Alvarado M; Ewing C; Esserman L; Fowble B Int J Radiat Oncol Biol Phys; 2011 May; 80(1):25-30. PubMed ID: 20646871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]